"Pharmacoequity" in Heart Failure Treatment: A Right for Everyone, Not Just a Select Few.
作者信息
Bolakale-Rufai Ikeoluwapo Kendra, Breathett Khadijah
机构信息
Department of Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Division of Cardiovascular Medicine, Indiana University, Indianapolis, Indiana, USA.
出版信息
JACC Heart Fail. 2025 Jan;13(1):72-74. doi: 10.1016/j.jchf.2024.10.015.
Abstract
摘要
相似文献
1
"Pharmacoequity" in Heart Failure Treatment: A Right for Everyone, Not Just a Select Few.心力衰竭治疗中的“药物公平性”：这是每个人的权利，而非少数人的特权。
JACC Heart Fail. 2025 Jan;13(1):72-74. doi: 10.1016/j.jchf.2024.10.015.
2
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.消除心房颤动、心力衰竭和血脂异常中的健康差异：实现药物平等的途径。
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
3
Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to Everyone.药物经济学与过敏诊所中的生物制剂：每次都为每个人在恰当的时间提供恰当的护理。
J Allergy Clin Immunol Pract. 2024 May;12(5):1170-1180. doi: 10.1016/j.jaip.2024.02.039. Epub 2024 Mar 6.
4
Pharmacoequity measurement framework: A tool to reduce health disparities.药物公平性衡量框架：一种减少健康差距的工具。
J Manag Care Spec Pharm. 2025 Feb 1;31(2):214-224. doi: 10.18553/jmcp.2025.31.2.214.
5
Pharmacoequity measurement framework: A tool to reduce health disparities.药物公平性衡量框架：一种减少健康差距的工具。
J Manag Care Spec Pharm. 2024 Dec 20:1-11. doi: 10.18553/jmcp.2025.24298.
6
Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association.实现心力衰竭护理公平的实施科学：美国心脏协会的科学声明。
Circulation. 2024 May 7;149(19):e1143-e1163. doi: 10.1161/CIR.0000000000001231. Epub 2024 Apr 3.
7
Achieving Health Equity in the Care of Patients with Heart Failure.实现心力衰竭患者护理中的健康公平。
Curr Cardiol Rep. 2023 Dec;25(12):1769-1781. doi: 10.1007/s11886-023-01994-4. Epub 2023 Nov 17.
8
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress.追求药物公平：决定因素、驱动因素及前进途径
J Health Polit Policy Law. 2022 Dec 1;47(6):709-729. doi: 10.1215/03616878-10041135.
9
Paving a Path to Equity in Cardiorenal Care.为心脏肾脏护理中的公平公正铺平道路。
Semin Nephrol. 2024 Mar;44(2):151519. doi: 10.1016/j.semnephrol.2024.151519. Epub 2024 Jul 2.
10
Top five considerations for improving outcomes in black patients with heart failure: A guide for primary care clinicians.改善心力衰竭黑人患者结局的五大注意事项：基层医疗临床医生指南。
J Natl Med Assoc. 2024 Oct;116(5):499-507. doi: 10.1016/j.jnma.2023.11.008. Epub 2023 Nov 24.
本文引用的文献
1
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials.心力衰竭中的种族因素：全球PARADIGM-HF和PARAGON-HF试验的汇总参与者水平分析
JACC Heart Fail. 2025 Jan;13(1):58-71. doi: 10.1016/j.jchf.2024.08.008. Epub 2024 Aug 31.
2
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America.《2024年心力衰竭统计数据：美国心力衰竭学会2024年更新报告》
J Card Fail. 2025 Jan;31(1):66-116. doi: 10.1016/j.cardfail.2024.07.001. Epub 2024 Sep 24.
3
Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association.实现心力衰竭护理公平的实施科学：美国心脏协会的科学声明。
Circulation. 2024 May 7;149(19):e1143-e1163. doi: 10.1161/CIR.0000000000001231. Epub 2024 Apr 3.
4
A Policy Prescription for Reducing Health Disparities-Achieving Pharmacoequity.减少健康差距——实现药物公平的政策处方
JAMA. 2021 Nov 9;326(18):1793-1794. doi: 10.1001/jama.2021.17764.
Zotero 插件